Skip to Main Content

Paper Details

Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation.
Br J Haematol
4
2021
Author NameAffiliation
Claudia RossigUniversity Children's Hospital Muenster
Wolfgang E BerdelUniversity Hospital Muenster
  • 1 - 2

Datasets

Release 1.2